To investigate the mechanism for VCX inhibition of autophagy, we measured levels of the ATG proteins, BECN1 (beclin 1) and ATG12, following VCX treatment in different types of B cell lines and primary CLL cells. The gene discussed is BECN1; the disease is B-cell chronic lymphocytic leukemia.